在患有晚期心力衰竭的患者中,血清胆水平与功能能力之间的关联
Murat Karaçam1, Azmican Kaya2, Seda Tanyeri2
1Department of Cardiology, Bitlis State Hospital, Bitlis, Turkey.
Biomarkers in medicine
|May 26, 2025
概括
较低的血清胆水平与晚期心力衰竭患者的功能能力降低有关. 这一发现表明,可能是评估心力衰竭严重程度的有用生物标志物.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
背景情况:
- 科林是一种关键的心脏蛋白酶,对激活尿酸至关重要.
- 晚期心力衰竭的特点是心脏功能受损和运动能力降低.
研究的目的:
- 为了研究血清胆固醇水平与晚期心力衰竭患者的功能能力之间的关联.
- 确定血清胆是否是运动表现的独立预测因子.
主要方法:
- 在88名LVEF<25%的患者中进行了横截面研究.
- 通过ELISA测量血清中胆固醇水平.
- 通过心肺运动测试 (CPET) 评估的功能能力,以确定峰值氧气消耗 (峰值VO2).
- 使用多变量线性回归分析.
主要成果:
- 平均VO2峰值为13.6毫升/分钟/公斤;平均血清胆氨酸为1.7毫克/毫升.
- 血清胆氨酸水平是VO2峰值的独立预测因子 (系数:1.206,p=0.0007).
结论:
- 较低的血清胆固醇水平独立地与晚期心力衰竭中的功能能力降低有关.
- 科林可以作为临床评估,风险分层和心力衰竭治疗计划的宝贵生物标志物.
相关概念视频
Heart Failure III: Clinical Manifestations
61
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
61
Heart Failure II: Pathophysiology
62
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
62
Heart Failure VII: Nursing Interventions
149
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
149
Heart Failure VI: Adjunct Therapies
40
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure IV: Classification and Diagnostic Evaluation
47
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
47


